Clinical Trials Directory

Trials / Completed

CompletedNCT01539850

Safety Evaluation of the LGL102 in Obese Subjects Treated With OMS102

Safety Evaluation of the LGL102 in Obese Subjects Treated With OMS102. A Prospective Multicenter Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
IntraPace, Inc · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The main objective of this study is to evaluate the LGL102 implant safety in obese to morbidly obese subjects treated with OMS102 system. The effect of the therapy on body weight changes will be also evaluated.

Conditions

Interventions

TypeNameDescription
DEVICEOMS102Subjects will receive implanted OMS102 System.

Timeline

Start date
2010-03-01
Primary completion
2011-04-01
Completion
2011-09-01
First posted
2012-02-28
Last updated
2012-02-28

Locations

3 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT01539850. Inclusion in this directory is not an endorsement.